BR9106549A - 1-alcoois de pgf e seu uso como hipotensivos oculares - Google Patents

1-alcoois de pgf e seu uso como hipotensivos oculares

Info

Publication number
BR9106549A
BR9106549A BR919106549A BR9106549A BR9106549A BR 9106549 A BR9106549 A BR 9106549A BR 919106549 A BR919106549 A BR 919106549A BR 9106549 A BR9106549 A BR 9106549A BR 9106549 A BR9106549 A BR 9106549A
Authority
BR
Brazil
Prior art keywords
configuration
alpha
independently
indicate
pgf
Prior art date
Application number
BR919106549A
Other languages
English (en)
Inventor
David Frederick Woodward
Ming Fain Chan
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BR9106549A publication Critical patent/BR9106549A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
BR919106549A 1990-06-14 1991-06-11 1-alcoois de pgf e seu uso como hipotensivos oculares BR9106549A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/538,204 US5238961A (en) 1990-06-14 1990-06-14 Pgf 1-alcohols and their use as ocular hypotensives
PCT/US1991/004103 WO1991019490A1 (en) 1990-06-14 1991-06-11 Pgf 1-alcohols and their use as ocular hypotensives

Publications (1)

Publication Number Publication Date
BR9106549A true BR9106549A (pt) 1993-06-01

Family

ID=24145936

Family Applications (1)

Application Number Title Priority Date Filing Date
BR919106549A BR9106549A (pt) 1990-06-14 1991-06-11 1-alcoois de pgf e seu uso como hipotensivos oculares

Country Status (13)

Country Link
US (1) US5238961A (pt)
EP (1) EP0533828B1 (pt)
JP (1) JP3139766B2 (pt)
KR (1) KR100196769B1 (pt)
AT (1) ATE141163T1 (pt)
AU (1) AU638587B2 (pt)
BR (1) BR9106549A (pt)
CA (1) CA2084769A1 (pt)
DE (1) DE69121408T2 (pt)
ES (1) ES2090341T3 (pt)
HU (1) HUT63371A (pt)
IE (1) IE912011A1 (pt)
WO (1) WO1991019490A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270049A (en) * 1990-11-09 1993-12-14 Allergan, Inc. 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives
US5139491A (en) * 1990-12-06 1992-08-18 Allergan, Inc. 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives
WO1992013836A1 (en) * 1991-02-07 1992-08-20 Allergan, Inc. 2-decarboxyl-2-hydroxyalkyl-5-trans prostaglandin f derivatives
US5312832A (en) * 1991-05-17 1994-05-17 Allergan, Inc. Ocular hypotensive 2-decarboxyl-2-acylthioalkyl prostaglandin derivatives
US5288754A (en) * 1992-02-04 1994-02-22 Allergan, Inc. Polar C-1 esters of prostaglandins
US5834498A (en) * 1992-09-21 1998-11-10 Allergan Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US6124353A (en) * 1992-11-12 2000-09-26 Allergan Sales, Inc. Method of treating ocular hypertension with 8-epi prostaglandins
US5476872A (en) * 1993-10-18 1995-12-19 Allergan, Inc. 1,11-diesters of prostaglandin-F2α having a polar ester group at C-1
US5545665A (en) * 1993-12-28 1996-08-13 Allergan Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
US6441047B2 (en) 1995-11-17 2002-08-27 Alcon Manufacturing Ltd.. Combination therapy for treating glaucoma
EP0912507B1 (en) * 1996-05-28 2002-02-06 Allergan Sales, Inc. Cyclopentan(en)oic acid, 2-alkenyl derivatives as therapeutic agents in the treatment of ocular hypertension
US6770675B2 (en) 1997-03-17 2004-08-03 Novartis Ag Compositions and methods for reducing ocular hypertension
WO2001055102A1 (fr) * 2000-01-28 2001-08-02 Asahi Glass Company, Limited Nouveau derive difluoroprostaglandine
US6414021B1 (en) * 2000-08-25 2002-07-02 Sucampo Ag Control of intraocular pressure during surgery
US20040216749A1 (en) * 2003-01-23 2004-11-04 Hosheng Tu Vasomodulation during glaucoma surgery
US20040151691A1 (en) 2003-01-30 2004-08-05 Oxman Joel D. Hardenable thermally responsive compositions
US6949518B1 (en) 2003-06-25 2005-09-27 Pao-Hsien Chu Methods for treating macular degeneration with topiramate
US20090148527A1 (en) * 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4055593A (en) * 1971-02-19 1977-10-25 Alza Corporation Alkyl diethers of prostaglandins
US3940438A (en) * 1971-05-24 1976-02-24 Alza Corporation Crystalline racemic 9α,11α,15(S)-trihydroxy-5-cis,13-trans-prostadienoic acid
US3853854A (en) * 1971-06-24 1974-12-10 Alza Corp Novel 5{40 ,6{40 -dihydro-2h-pyran-4{40 -yl prostaglandin ethers
US4001306A (en) * 1971-12-30 1977-01-04 The Upjohn Company Prostaglandin F.sub.α 15-monoacrylates
US3941886A (en) * 1973-09-21 1976-03-02 Alza Corporation Pharmaceutical compositions containing crystalline racemic 9α, 11α, 15(S)-trihydroxy-5-cis, 13-trans-prostadienoic acid
NL7605381A (nl) * 1975-05-26 1976-11-30 Schering Ag Werkwijze voor het bereiden van prostaanderi- vaten en werkwijze voor het bereiden van een geneesmiddel met prostaglandinewerking.
US4025577A (en) * 1975-06-12 1977-05-24 Exxon Research And Engineering Company Hydroalkylation of paraffins with olefins utilizing hydrogen fluoride and metal pentafluoride catalyst
US4049678A (en) * 1976-03-29 1977-09-20 The Upjohn Company 9-Deoxy-PGD-type, 1,15-lactones
US4201873A (en) * 1975-09-17 1980-05-06 The Upjohn Company 9-Deoxy-9,10-didehydro-PGD2 analogs
US4033989A (en) * 1975-09-17 1977-07-05 The Upjohn Company 9-Deoxy-PGF2 Analogs
US4016184A (en) * 1975-09-17 1977-04-05 The Upjohn Company 9-Deoxy-9,10-didehydro-PGD1 compounds
US4060540A (en) * 1975-09-18 1977-11-29 American Cyanamid Company Novel 3-triphenylmethoxy-1-alkynes, 3-triphenyl-methoxy-1-trans-alkenyl-dialkyl-alanes, and lithium 3-triphenylmethoxy-1-trans-alkenyl-dialkyl alanates
GB2048254B (en) * 1979-04-02 1983-05-25 Upjohn Co 19,20 -didehydro-19-hydroxy and 19-oxo-prostaglandin derivatives
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
US4883819A (en) * 1986-07-31 1989-11-28 The Trustees Of Columbia University In The City Of New York Use of A, B and C prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma
US4824857A (en) * 1986-05-16 1989-04-25 Yasumasa Goh Use of prostaglandin D2 -active substances
US4822819A (en) * 1986-11-07 1989-04-18 Alcon Laboratories, Inc. Use of trimoprostil and derivatives in glaucoma therapy
ZA88963B (en) * 1987-02-27 1989-11-29 Allergan Inc Prostaglandins useful for lowering intraocular pressure
ES2042625T5 (es) * 1987-04-03 2000-07-16 Univ Columbia Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.
SE8703854D0 (sv) * 1987-10-07 1987-10-07 Pharmacia Ab Prostaglandinderivat for behandling av glaukom eller okuler hypertension
US5139491A (en) * 1990-12-06 1992-08-18 Allergan, Inc. 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives
WO1992013836A1 (en) * 1991-02-07 1992-08-20 Allergan, Inc. 2-decarboxyl-2-hydroxyalkyl-5-trans prostaglandin f derivatives

Also Published As

Publication number Publication date
US5238961A (en) 1993-08-24
HUT63371A (en) 1993-08-30
JPH05507928A (ja) 1993-11-11
EP0533828A4 (en) 1993-08-11
AU638587B2 (en) 1993-07-01
IE912011A1 (en) 1991-12-18
DE69121408D1 (de) 1996-09-19
DE69121408T2 (de) 1997-02-20
ES2090341T3 (es) 1996-10-16
HU9203920D0 (en) 1993-03-29
EP0533828A1 (en) 1993-03-31
ATE141163T1 (de) 1996-08-15
JP3139766B2 (ja) 2001-03-05
AU8053991A (en) 1992-01-07
KR100196769B1 (ko) 1999-06-15
CA2084769A1 (en) 1991-12-15
WO1991019490A1 (en) 1991-12-26
EP0533828B1 (en) 1996-08-14

Similar Documents

Publication Publication Date Title
BR9106549A (pt) 1-alcoois de pgf e seu uso como hipotensivos oculares
DK0410785T3 (da) 11-Acylprostaglandiner, som reducerer intraokulartryk
KR830002687A (ko) 성기능조절 수용성 펩타이드
ES2130599T3 (es) Pseudoceramidas.
NO810479L (no) Fremgangsmaate for fremstilling av terapeutisk aktive substituerte imidazolderivater
ES2040879T3 (es) Procedimiento de preparacion de derivados pirimidinilaminicos de piperidina.
ES2062443T3 (es) Nuevos derivados peptidicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
YU2692A (sh) Novi derivati tetrazola i postupak za njihovo pripremanje
ES496880A0 (es) Un procedimiento para la preparacion de derivados de benzofurano.
FI812804L (fi) 2-(1,4-bensodioxan-2-ylalkyl)-imidazoler anvaendbara som antidepressiva laekemedel
SE7701778L (sv) 2,9-dioxatricyklo /4,3,1,0?723?717/ dekaner och forfarande for framstellning derav
MX9204457A (es) Compuestos de 6-oxo-azepinoidol, asi como procedimientos y productos intermedios para su preparacion, y medicamentos que contienen estos compuestos.
BR9107155A (pt) 2-decarboxil-2-alcoxialquil prostaglandinas como hipotensivos oculares
LV10098A (lv) Metilpiperazinazepina atvasinajumi to iegusana un lietosana
SE8007569L (sv) Fosningsmedel jemte sett att dermed framstella stabila losningar lempliga for parenteral administration
KR830006229A (ko) 이미다졸 유도체의 제조방법
ES2032838T3 (es) Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol.
ATE164763T1 (de) Okulare hypotensive homo-prostaglandinderivate
ES2038389T3 (es) Procedimiento para la obtencion de 3-aminosidnoniminas substituidas farmacologicamente activas.
ES465221A1 (es) Procedimiento para la preparacion de nuevos derivados de 4- ter-buti-3'-clorodifenilamina con actividad antihistaminica.
ES2088489T3 (es) Uso de prostaglandina f3alfa como agente ocular hipotensivo.
ES467519A1 (es) Un procedimiento de preparacion de acidos furoil- o tenoil- naftiloxialcohilcarboxilicos.
DK101085D0 (da) Carbacycliner, fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler
KR920002139A (ko) 뇌혈관 수축 치료제
ES8604507A1 (es) Procedimiento de preparacion de las prostaglandinas del tipo 12-epi-pgf2b

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal